These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 23865864

  • 1. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
    Xu M, Ju W, Hao H, Wang G, Li P.
    Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
    [Abstract] [Full Text] [Related]

  • 2. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors.
    Jiang JG, Chen CL, Card JW, Yang S, Chen JX, Fu XN, Ning YG, Xiao X, Zeldin DC, Wang DW.
    Cancer Res; 2005 Jun 01; 65(11):4707-15. PubMed ID: 15930289
    [Abstract] [Full Text] [Related]

  • 3. Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines.
    Jiang JG, Fu XN, Chen CL, Wang DW.
    Ai Zheng; 2009 Feb 01; 28(2):93-6. PubMed ID: 19550113
    [Abstract] [Full Text] [Related]

  • 4. Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes.
    Aliwarga T, Evangelista EA, Sotoodehnia N, Lemaitre RN, Totah RA.
    Int J Mol Sci; 2018 Jun 29; 19(7):. PubMed ID: 29966295
    [Abstract] [Full Text] [Related]

  • 5. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X, Zhang XA, Wang DW.
    Adv Drug Deliv Rev; 2011 Jul 18; 63(8):597-609. PubMed ID: 21477627
    [Abstract] [Full Text] [Related]

  • 6. Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
    Ren S, Zeng J, Mei Y, Zhang JZ, Yan SF, Fei J, Chen L.
    Drug Metab Dispos; 2013 Jan 18; 41(1):60-71. PubMed ID: 23033255
    [Abstract] [Full Text] [Related]

  • 7. Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes.
    Nakayama K, Nitto T, Inoue T, Node K.
    Life Sci; 2008 Aug 29; 83(9-10):339-45. PubMed ID: 18675280
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
    Liu PY, Li YH, Chao TH, Wu HL, Lin LJ, Tsai LM, Chen JH.
    Atherosclerosis; 2007 Nov 29; 195(1):199-206. PubMed ID: 17126841
    [Abstract] [Full Text] [Related]

  • 9. Cytochrome p450 epoxygenase promotes human cancer metastasis.
    Jiang JG, Ning YG, Chen C, Ma D, Liu ZJ, Yang S, Zhou J, Xiao X, Zhang XA, Edin ML, Card JW, Wang J, Zeldin DC, Wang DW.
    Cancer Res; 2007 Jul 15; 67(14):6665-74. PubMed ID: 17638876
    [Abstract] [Full Text] [Related]

  • 10. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
    Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, Börgel J, Mügge A, Lindpaintner K, Huesing A, Maisch B, Zeldin DC, Liao JK.
    Circulation; 2004 Oct 12; 110(15):2132-6. PubMed ID: 15466638
    [Abstract] [Full Text] [Related]

  • 11. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
    Shahabi P, Siest G, Meyer UA, Visvikis-Siest S.
    Pharmacol Ther; 2014 Nov 12; 144(2):134-61. PubMed ID: 24882266
    [Abstract] [Full Text] [Related]

  • 12. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
    Li R, Xu X, Chen C, Wang Y, Gruzdev A, Zeldin DC, Wang DW.
    Am J Physiol Endocrinol Metab; 2015 Feb 15; 308(4):E270-82. PubMed ID: 25389363
    [Abstract] [Full Text] [Related]

  • 13. Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.
    Spiecker M, Liao J.
    Trends Cardiovasc Med; 2006 Aug 15; 16(6):204-8. PubMed ID: 16839864
    [Abstract] [Full Text] [Related]

  • 14. Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
    Chen F, Chen C, Yang S, Gong W, Wang Y, Cianflone K, Tang J, Wang DW.
    PLoS One; 2012 Aug 15; 7(6):e39197. PubMed ID: 22761738
    [Abstract] [Full Text] [Related]

  • 15. CYP2J2 - regulation, function and polymorphism.
    Murray M.
    Drug Metab Rev; 2016 Aug 15; 48(3):351-68. PubMed ID: 27286171
    [Abstract] [Full Text] [Related]

  • 16. Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
    Moshal KS, Zeldin DC, Sithu SD, Sen U, Tyagi N, Kumar M, Hughes WM, Metreveli N, Rosenberger DS, Singh M, Vacek TP, Rodriguez WE, Ayotunde A, Tyagi SC.
    J Cell Physiol; 2008 Jun 15; 215(3):771-81. PubMed ID: 18181170
    [Abstract] [Full Text] [Related]

  • 17. Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors.
    Leow JWH, Verma RK, Lim ABH, Fan H, Chan ECY.
    Eur J Pharm Sci; 2021 Sep 01; 164():105889. PubMed ID: 34044117
    [Abstract] [Full Text] [Related]

  • 18. Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity.
    Solanki M, Pointon A, Jones B, Herbert K.
    Drug Metab Dispos; 2018 Aug 01; 46(8):1053-1065. PubMed ID: 29695613
    [Abstract] [Full Text] [Related]

  • 19. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X, Zhang D, Dou X, Niu N, Huang W, Bai J, Zhang G.
    BMC Cancer; 2014 Nov 18; 14():841. PubMed ID: 25406731
    [Abstract] [Full Text] [Related]

  • 20. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
    Shahabi P, Siest G, Visvikis-siest S.
    Drug Metab Rev; 2014 Feb 18; 46(1):33-56. PubMed ID: 24040964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.